# Continued Safety and Performance of the TIVUS System

> **NCT01835535** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Cardiosonic** · enrollment: 80 (estimated)

## Conditions studied

- Hypertension, Resistant to Conventional Therapy

## Interventions

- **DEVICE:** TIVUS

## Key facts

- **NCT ID:** NCT01835535
- **Lead sponsor:** Cardiosonic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2014-06
- **Final completion:** 2016-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2014-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01835535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01835535, "Continued Safety and Performance of the TIVUS System". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01835535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*